Citation Tools

Download PDFPDF
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout

Download to a citation manager

Cite this article as:
Reinders MK, Haagsma C, Jansen TLTA, et al
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout